Refractory Langerhans cell histiocytosis Active Not Recruiting Phase 2 Trials for Olaparib (DB09074)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0022006 (Refractory Langerhans cell histiocytosis) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03233204 | Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) | Treatment |